Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen.

Sendur, Mehmet Ali Nahit; Ozdemir, Nuriye; Özatli, Tahsin; Yazici, Ozan; Aksoy, Sercan; Ekinci, Ahmet Siyar; Yazilitas, Dogan; Günaydin, Yusuf; Oksuzoglu, Berna; Benekli, Mustafa; Zengin, Nurullah

Sendur, Mehmet Ali Nahit; Ozdemir, Nuriye; Özatli, Tahsin; Yazici, Ozan; Aksoy, Sercan; Ekinci, Ahmet Siyar; Yazilitas, Dogan; Günaydin, Yusuf; Oksuzoglu, Berna; Benekli, Mustafa; Zengin, Nurullah.

Affiliation

Sendur MA; Department of Medical Oncology, Faculty of Medicine, Yildirim Beyazit University, 06800, Ankara, Turkey, masendur@yahoo.com.tr.

Med Oncol ; 31(9): 153, 2014 Sep.

Article in En | MEDLINE | ID: mdl-25099765

Subject(s)

Antineoplastic Agents/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Stomach Neoplasms; Adult; Aged; Antineoplastic Agents/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Camptothecin/analogs & derivatives; Febrile Neutropenia; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms/drug therapy; Stomach Neoplasms/epidemiology; Stomach Neoplasms/pathology; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Med Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google